Iron overload in β-thalassemia intermedia: an emerging concern
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Purpose of review The aim is to overview recent evidence on consequences, assessment, and management of iron overload in transfusion-independent patients with β-thalassemia intermedia. Recent findings Despite their transfusion-independence, β-thalassemia intermedia patients can still accumulate iron due to increased intestinal absorption. Recent observational studies show that iron burden in this group of patients can ultimately reach considerably high thresholds, and leads to a variety of serious morbidities involving the liver, endocrine glands, and arguably the vascular system. The diagnosis of iron overload in this patient population can follow established guidelines from β-thalassemia major patients, although with careful interpretation of spot serum ferritin levels. Data from a recent randomized clinical trial demonstrated the efficacy and safety of iron chelation therapy in decreasing liver iron concentration in this group of patients, which may ultimately help in reducing morbidity risk. Summary Iron overload in transfusion-independent patients with β-thalassemia intermedia deserves careful attention, and prompt diagnosis and management are recommended.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anaemia owing to ineffective erythropoiesis, as occurs most prominently in patients with β-thalassaemia, is associated with severe iron overload that develops even in the absence of blood transfusions but is exacerbated in patients who receive repeated transfusions36,37.”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [36]
Citations
Cites
Taher, A. T., Musallam, K. M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., Saned, M.-S., El-Chafic, A.-H., Fasulo, M. R., & Cappellini, M. D. (2010) · Blood · doi:10.1182/blood-2009-09-243154 · Cited by 392
Self-citationLiver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365 · cited 2×
“Increased intestinal iron absorption in thalassemia intermedia patients eventually leads to portal and hepatocyte iron loading [8], with subsequent release into the circulation of free iron species (nontransferrin-bound iron, NTBI) that are usually associated with target-organ damage [9].”
BackgroundHepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Gardenghi, S., Ramos, P., Marongiu, M. F., Melchiori, L., Breda, L., Guy, E., Muirhead, K., Rao, N., Roy, C. N., Andrews, N. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41717 · Cited by 220 · cited 1×
“Studies on mouse models mimicking human thalassemia intermedia (exhibiting nontransfusion dependent anemia, aberrant erythrocyte morphology, hepatosplenomegaly, and iron overload) not only suggested a potential role for hepcidin and transferrin therapy to decrease iron overload but also showed beneficial effects on in…”
BackgroundOptimal management of β thalassaemia intermedia
Taher, A. T., Musallam, K. M., Cappellini, M. D., & Weatherall, D. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08486.x · Cited by 207
Self-citationGinzburg, Y., & Rivella, S. (2011) · Blood · doi:10.1182/blood-2011-03-283614 · Cited by 201
Transferrin therapy ameliorates disease in β-thalassemic mice
Li, H., Rybicki, A. C., Suzuka, S. M., von Bonsdorff, L., Breuer, W., Hall, C. B., Cabantchik, Z. I., Bouhassira, E. E., Fabry, M. E., & Ginzburg, Y. Z. (2010) · Nature Medicine · doi:10.1038/nm.2073 · Cited by 192
Musallam, K. M., Cappellini, M. D., Wood, J. C., Motta, I., Graziadei, G., Tamim, H., & Taher, A. T. (2011) · Haematologica · doi:10.3324/haematol.2011.047852 · Cited by 177
Self-citationDeletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Nai, A., Pagani, A., Mandelli, G., Lidonnici, M. R., Silvestri, L., Ferrari, G., & Camaschella, C. (2012) · Blood · doi:10.1182/blood-2012-01-401885 · Cited by 161
Taher, A. T., Porter, J., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., Siritanaratkul, N., Galanello, R., Karakas, Z., Lawniczek, T., et al. (2012) · Blood · doi:10.1182/blood-2012-02-412692 · Cited by 147
Self-citationImpact of Iron Assessment by MRI
Wood, J. C. (2011) · Hematology · doi:10.1182/asheducation-2011.1.443 · Cited by 143
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective
Musallam, K. M., Cappellini, M. D., Wood, J. C., & Taher, A. T. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70006-1 · Cited by 139
Self-citationAge‐related complications in treatment‐naïve patients with thalassaemia intermedia
Taher, A. T., Musallam, K. M., El‐Beshlawy, A., Karimi, M., Daar, S., Belhoul, K., Saned, M., Graziadei, G., & Cappellini, M. D. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08220.x · Cited by 134
Self-citation-Thalassemia Intermedia: A Clinical Perspective
Musallam, K. M., Taher, A. T., & Rachmilewitz, E. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013482 · Cited by 133
Self-citationTaher, A., El Rassi, F., Isma'eel, H., Koussa, S., Inati, A., & Cappellini, M. D. (2008) · Haematologica · doi:10.3324/haematol.13098 · Cited by 129
Self-citationPakbaz, Z., Fischer, R., Fung, E., Nielsen, P., Harmatz, P., & Vichinsky, E. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21275 · Cited by 128
The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia
Rivella, S. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70005-x · Cited by 126
Cerebral infarction in β-thalassemia intermedia: Breaking the silence
Musallam, K. M., Taher, A. T., Karimi, M., & Rachmilewitz, E. A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.07.013 · Cited by 92
Self-citationTaher, A. T., Musallam, K. M., Wood, J. C., & Cappellini, M. D. (2009) · American Journal of Hematology · doi:10.1002/ajh.21626 · Cited by 77
Self-citationRisk factors for pulmonary hypertension in patients with β thalassemia intermedia
Karimi, M., Musallam, K. M., Cappellini, M. D., Daar, S., El-Beshlawy, A. M., Belhoul, K., Saned, M., Temraz, S. N., Koussa, S., & Taher, A. T. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.05.013 · Cited by 68
Self-citationTaher, A., Musallam, K. M., El Rassi, F., Duca, L., Inati, A., Koussa, S., & Cappellini, M. D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07810.x · Cited by 68
Self-citationBrain magnetic resonance angiography in splenectomized adults with β-thalassemia intermedia
Musallam, K. M., Beydoun, A. A., Hourani, R. G., Nasreddine, W., Raad, R. A., Koussa, S., & Taher, A. T. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01706.x · Cited by 55
Self-citationMusallam, K. M., Motta, I., Salvatori, M., Fraquelli, M., Marcon, A., Taher, A. T., & Cappellini, M. D. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.06.001 · Cited by 55
Self-citationMaakaron, J. E., Cappellini, Graziadei, G., Ayache, J. B., & Taher, A. T. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31397-3 · Cited by 52
Self-citationThrombosis in Thalassemia: Why are we so Concerned?
Musallam, K. M., & Taher, A. T. (2011) · Hemoglobin · doi:10.3109/03630269.2011.605499 · Cited by 49
Self-citationZiyadeh, F. N., Musallam, K. M., Mallat, N. S., Mallat, S. G., Jaber, F., Suwaidan, A. A., Koussa, S., & Taher, A. T. (2012) · Nephron Clinical Practice · doi:10.1159/000339787 · Cited by 41
Self-citationMusallam, K. M., Nasreddine, W., Beydoun, A. A., Hourani, R. G., Hankir, A. K., Koussa, S., Haidar, M., & Taher, A. T. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1291-3 · Cited by 29
Self-citationParrow, N. L., Gardenghi, S., Ramos, P., Casu, C., Grady, R. W., Anderson, E. R., Shah, Y. M., Li, H., Ginzburg, Y. Z., Fleming, R. E., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405563 · Cited by 28
Serum Ferritin Levels and Morbidity in β-Thalassemia Intermedia: A 10-Year Cohort Study
Musallam, K. M., Cappellini, M. D., Daar, S., Karimi, M., El-Beshlawy, A. M., & Taher, A. T. (2012) · Blood · doi:10.1182/blood.v120.21.1021.1021 · Cited by 15
Self-citationTaher, A. T., Porter, J. B., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., Siritanaratkul, N., Galanello, R., Karakaş, Z., Lawniczek, T., et al. (2012) · Blood · doi:10.1182/blood.v120.21.3258.3258 · Cited by 5
Self-citationMusallam, K. M., Cappellini, M. D., & Taher, A. T. (2012) · Blood · doi:10.1182/blood.v120.21.1024.1024 · Cited by 3
Self-citation
Research works printed but not linked: 3
- Taher, 2012, Haematologica, 96, 0924
- Taher, 2012, Blood, 120, 3258, 10.1182/blood-2012-02-412692 · DOI · Paper page
- Taher, 2012, Haematologica, 96, 0927
Cited by
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843
Non-transfusion-dependent thalassemias
Musallam, K. M., Rivella, S., Vichinsky, E., & Rachmilewitz, E. A. (2013) · Haematologica · doi:10.3324/haematol.2012.066845 · Cited by 326
Self-citationFerritin: The Protein Nanocage and Iron Biomineral in Health and in Disease
Theil, E. C. (2013) · Inorganic Chemistry · doi:10.1021/ic400484n · Cited by 244
How I manage medical complications of β-thalassemia in adults
Taher, A. T., & Cappellini, M. D. (2018) · Blood · doi:10.1182/blood-2018-06-818187 · Cited by 145
Self-citationΑlpha-thalassemia: A practical overview
Musallam, K. M., Cappellini, M. D., Coates, T. D., Kuo, K. H. M., Al-Samkari, H. T., Sheth, S., Viprakasit, V., & Taher, A. T. (2024) · Blood Reviews · doi:10.1016/j.blre.2023.101165 · Cited by 117
Self-citation
Metadata
- Authors
- Musallam, K. M., Cappellini, M. D., & Taher, A. T.
- Affiliations
- University of Milan (IT)
- American University of Beirut Medical Center (LB)
- Corresponding author
- Taher, Ali T.
- Venue
- Current Opinion in Hematology
- Published
- 2013-05
- Volume
- 20
- Issue
- 3
- Pages
- 187-192
- ISSN
- 1065-6251 (ISSN-L)
- OpenAlex
- W2064749326
- Cited by
- 50
- References
- 30
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 6 · 2014: 6 · 2013: 5
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Hematology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Keywords
- iron overload, beta-thalassemia intermedia, intestinal iron absorption, serum ferritin, iron chelation therapy, liver iron concentration
- MeSH terms
- Humans, Iron Chelating Agents, beta-Thalassemia, Iron Overload
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.